We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Rexahn Awarded U.S. Patent for Novel Anti-Cancer Compounds

News   Jun 19, 2013

 
Rexahn Awarded U.S. Patent for Novel Anti-Cancer Compounds
 
 
 

RELATED ARTICLES

Fungus Chemistry May Mimic Opioids With Fewer Side Effects

News

The hunt for an opioid alternative has made a leap forward – a unique fungus may be able to mimic opioid suggesting it could be a safer less addictive drug, helping address the opioid epidemic of deaths by overdose.

READ MORE

Post-surgery Surveillance – Less May Be More for Low-risk Thyroid Cancer Patients

News

A study has found that some patients, known as maximizers, consume a high level of medical resources without clear evidence of better outcomes.

READ MORE

New Genetic Engineering Tool Opens Floodgates of Microbial Metabolite Applications

News

A team of microbiologists and genomicists led by the Department of Energy Joint Genome Institute (JGI) has invented a genetic engineering tool, called CRAGE, that could not only make studying microbes much easier, but also fill significant gaps in our understanding of how microbes interact with their surroundings and evolve.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE